Form 4: Doximity CFO Anna Bryson Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Doximity's CFO, Anna Bryson, exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On August 8 and 9, 2024, Anna Bryson, the Chief Financial Officer of Doximity, Inc., engaged in transactions involving the company's stock.
- Bryson exercised stock options to acquire Class A Common Stock.
- These options were granted on various dates and vest in monthly installments.
- She also converted Class B Common Stock into Class A Common Stock.
- Additionally, Bryson sold 30,000 shares of Class A Common Stock at a price of $35 per share on August 9, 2024.
- These sales were executed automatically under a Rule 10b5-1 trading plan adopted on November 30, 2023.
- Following these transactions, Bryson directly owns 309,627 shares of Class A Common Stock and holds options for 607,268 shares of Class B Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions appear to be routine and conducted under a pre-arranged plan. There's no indication of unusual activity or cause for alarm.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
Risks
- Executive stock sales, even under a 10b5-1 plan, can sometimes be perceived negatively by investors.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, and are often scrutinized by investors for insights into management's perspective on the company's future prospects.
Comparison to Industry Standards
- It's common for executives at publicly traded companies like Doximity to have stock option plans as part of their compensation.
- The use of 10b5-1 trading plans is a standard practice to allow insiders to sell shares without raising concerns about insider trading, similar to practices at companies like Teladoc or GoodRx.
- The vesting schedules and exercise prices of the options are within typical ranges for tech companies of Doximity's size.
Stakeholder Impact
- The sale of shares by a key executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2019-05-15 | Date from which stock option vested in 48 equal monthly installments. |
| 2020-05-01 | Date from which stock option vested in 48 equal monthly installments. |
| 2021-02-01 | Date from which stock option vested in 60 equal monthly installments. |
| 2023-11-30 | Date the Reporting Person adopted a Rule 10b5-1 trading plan. |
| 2024-08-08 | Date of stock option exercise and conversion of Class B Common Stock to Class A Common Stock. |
| 2024-08-09 | Date of stock option exercise, conversion of Class B Common Stock to Class A Common Stock, and sale of Class A Common Stock. |
| 2029-05-14 | Expiration date of stock option. |
| 2030-06-09 | Expiration date of stock option. |
| 2031-02-04 | Expiration date of stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.